Our top pick for
Knoll Inc is a commercial services & supplies business based in the US. Knoll shares (KNL) are listed on the NYSE and all prices are listed in US Dollars. Knoll employs 3,082 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.62|
|52-week range||$0.59 - $26.62|
|50-day moving average||$25.98|
|200-day moving average||$20.83|
|Wall St. target price||$25.00|
|Dividend yield||$0.22 (0.89%)|
|Earnings per share (TTM)||$-0.21|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-20)||N/A|
|1 month (2022-05-28)||N/A|
|3 months (2022-03-28)||N/A|
|6 months (2021-12-28)||N/A|
|1 year (2021-07-01)||-97.66%|
|2 years (2020-07-01)||-94.62%|
|3 years (2019-07-01)||23.2|
|5 years (2017-06-30)||20.05|
Valuing Knoll stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Knoll's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Knoll's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.91. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Knoll's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Knoll's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $103.1 million.
The EBITDA is a measure of a Knoll's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.2 billion|
|Operating margin TTM||5.19%|
|Gross profit TTM||$444.1 million|
|Return on assets TTM||2.55%|
|Return on equity TTM||-1.01%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
Dividend payout ratio: 43.9% of net profits
Recently Knoll has paid out, on average, around 43.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.95% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Knoll shareholders could enjoy a 0.95% return on their shares, in the form of dividend payments. In Knoll's case, that would currently equate to about $0.22 per share.
While Knoll's payout ratio might seem fairly standard, it's worth remembering that Knoll may be investing much of the rest of its net profits in future growth.
Knoll's most recent dividend payout was on 29 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 June 2021 (the "ex-dividend date").
Over the last 12 months, Knoll's shares have ranged in value from as little as $0.59 up to $26.62. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Knoll's is 2.0669. This would suggest that Knoll's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Knoll, Inc. , together with its subsidiaries, designs, manufactures, markets, and sells commercial and residential furniture, accessories, and coverings for the workplace and residential markets in the United States, Canada, Europe, and internationally. The company operates through Office and Lifestyle segments. It provides systems furniture, including integrated panels or table desks, work surfaces and storage units, power and data systems, and lighting products; office seating products comprising various work chairs; and files and storage products, such as lateral files, mobile pedestals and other storage units, bookcases, and overhead cabinets. The company also offers adjustable tables, as well as meeting, conference, training, dining, and stand-alone and table desks; conference furniture product platforms; height desks, tables, and ergonomic seating and accessories principally for individual home offices and small businesses; technology support accessories, desktop organizational tools, and lighting and storage products; seating and lounge furniture, as well as side, café, and dining chairs; conference, training, dining, and occasional tables; and lighting, rugs, textiles, fabrics, felt, leather, upholstery, drapery, and related architectural products. It serves Fortune 1000 companies, governmental agencies, and other medium-to-large sized organizations in various industries, including financial, legal, technology, entertainment, accounting, education, healthcare, and hospitality through its direct sales force and showrooms, distribution partners, and independent dealers and retailers, as well as online. The company was founded in 1938 and is headquartered in East Greenville, Pennsylvania.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.